{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:48:44Z","timestamp":1792784924859,"version":"4.5.0"},"reference-count":91,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T00:00:00Z","timestamp":1787616000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:00:00Z","timestamp":1790208000000},"content-version":"vor","delay-in-days":30,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Medical and Health Technology Innovation Project of Chinese Academy of Medical Sciences","id":[{"id":"https:\/\/ror.org\/02drdmm93","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-026-76940-3","type":"journal-article","created":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T15:07:27Z","timestamp":1787670447000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mutant TP53 hijacks RNA-splicing factor RBM28 to suppress double-stranded RNA triggered antitumor immunity"],"prefix":"10.1038","volume":"17","author":[{"given":"Tao","family":"Xiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyi","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0381-827X","authenticated-orcid":false,"given":"Xiaoyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaosen","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shihao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanzhang","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1313-8418","authenticated-orcid":false,"given":"Qingyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7231-7838","authenticated-orcid":false,"given":"Wen","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8723-8868","authenticated-orcid":false,"given":"Dongxin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4954-1011","authenticated-orcid":false,"given":"Chen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,25]]},"reference":[{"key":"76940_CR1","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.ccell.2024.04.009","volume":"42","author":"Y Liu","year":"2024","unstructured":"Liu, Y., Su, Z., Tavana, O. & Gu, W. Understanding the complexity of p53 in a new era of tumor suppression. Cancer Cell 42, 946\u2013967 (2024).","journal-title":"Cancer Cell"},{"key":"76940_CR2","doi-asserted-by":"publisher","first-page":"1370","DOI":"10.1016\/j.celrep.2019.07.001","volume":"28","author":"LA Donehower","year":"2019","unstructured":"Donehower, L. A. et al. Integrated analysis of TP53 gene and pathway alterations in The Cancer Genome Atlas. Cell Rep. 28, 1370\u20131384 (2019).","journal-title":"Cell Rep."},{"key":"76940_CR3","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1038\/s41586-022-05082-5","volume":"608","author":"T Baslan","year":"2022","unstructured":"Baslan, T. et al. Ordered and deterministic cancer genome evolution after p53 loss. Nature 608, 795\u2013802 (2022).","journal-title":"Nature"},{"key":"76940_CR4","doi-asserted-by":"publisher","first-page":"2038","DOI":"10.1016\/j.ccell.2023.11.003","volume":"41","author":"J Chang","year":"2023","unstructured":"Chang, J. et al. Genomic alterations driving precancerous to cancerous lesions in esophageal cancer development. Cancer Cell 41, 2038\u20132050 (2023).","journal-title":"Cancer Cell"},{"key":"76940_CR5","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1126\/science.aax3649","volume":"365","author":"S Boettcher","year":"2019","unstructured":"Boettcher, S. et al. A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies. Science 365, 599\u2013604 (2019).","journal-title":"Science"},{"key":"76940_CR6","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41588-024-02039-4","volume":"57","author":"JS Funk","year":"2025","unstructured":"Funk, J. S. et al. Deep CRISPR mutagenesis characterizes the functional diversity of TP53 mutations. Nat. Genet. 57, 140\u2013153 (2025).","journal-title":"Nat. Genet."},{"key":"76940_CR7","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1016\/j.ccell.2021.01.003","volume":"39","author":"M Ghosh","year":"2021","unstructured":"Ghosh, M. et al. Mutant p53 suppresses innate immune signaling to promote tumorigenesis. Cancer Cell 39, 494\u2013508 (2021).","journal-title":"Cancer Cell"},{"key":"76940_CR8","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1038\/s43018-024-00796-z","volume":"5","author":"G Efe","year":"2024","unstructured":"Efe, G., Rustgi, A. K. & Prives, C. p53 at the crossroads of tumor immunity. Nat. Cancer 5, 983\u2013995 (2024).","journal-title":"Nat. Cancer"},{"key":"76940_CR9","doi-asserted-by":"publisher","first-page":"4449","DOI":"10.1007\/s00018-020-03524-9","volume":"77","author":"G Carr\u00e0","year":"2020","unstructured":"Carr\u00e0, G., Lingua, M. F., Maffeo, B., Taulli, R. & Morotti, A. P53 vs NF-\u03baB: the role of nuclear factor-kappa B in the regulation of p53 activity and vice versa. Cell Mol. Life Sci. 77, 4449\u20134458 (2020).","journal-title":"Cell Mol. Life Sci."},{"key":"76940_CR10","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1016\/j.immuni.2024.08.015","volume":"57","author":"Z Nian","year":"2024","unstructured":"Nian, Z. et al. Interleukin-34-orchestrated tumor-associated macrophage reprogramming is required for tumor immune escape driven by p53 inactivation. Immunity 57, 2344\u20132361 (2024).","journal-title":"Immunity"},{"key":"76940_CR11","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/s41568-023-00653-8","volume":"24","author":"Y Liang","year":"2024","unstructured":"Liang, Y., Qu, X., Shah, N. M. & Wang, T. Towards targeting transposable elements for cancer therapy. Nat. Rev. Cancer 24, 123\u2013140 (2024).","journal-title":"Nat. Rev. Cancer"},{"key":"76940_CR12","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.immuni.2024.03.003","volume":"57","author":"M Yoneyama","year":"2024","unstructured":"Yoneyama, M., Kato, H. & Fujita, T. Physiological functions of RIG-I-like receptors. Immunity 57, 731\u2013751 (2024).","journal-title":"Immunity"},{"key":"76940_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.molcel.2020.07.026","volume":"80","author":"T Reisl\u00e4nder","year":"2020","unstructured":"Reisl\u00e4nder, T., Groelly, F. J. & Tarsounas, M. DNA damage and cancer immunotherapy: A STING in the tale. Mol. Cell 80, 21\u201328 (2020).","journal-title":"Mol. Cell"},{"key":"76940_CR14","doi-asserted-by":"publisher","first-page":"7248","DOI":"10.1016\/j.cell.2024.09.032","volume":"187","author":"L Xu","year":"2024","unstructured":"Xu, L. et al. IRE1\u03b1 silences dsRNA to prevent taxane-induced pyroptosis in triple-negative breast cancer. Cell 187, 7248\u20137266.e34 (2024).","journal-title":"Cell"},{"key":"76940_CR15","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.molcel.2024.11.025","volume":"85","author":"N Sasaki","year":"2025","unstructured":"Sasaki, N. et al. RNA sensing induced by chromosome missegregation augments anti-tumor immunity. Mol. Cell 85, 770\u2013786 (2025).","journal-title":"Mol. Cell"},{"key":"76940_CR16","doi-asserted-by":"publisher","first-page":"eado8758","DOI":"10.1126\/sciimmunol.ado8758","volume":"9","author":"Y Zhou","year":"2024","unstructured":"Zhou, Y., Zhang, Y., Li, M., Ming, T., Zhang, C., Huang, C., Li, J., Li, F., Li, H., Zhao, E. et al. Oncogenic KRAS drives immunosuppression of colorectal cancer by impairing DDX60-mediated dsRNA accumulation and viral mimicry. Sci. Immunol. 9, eado8758 (2024).","journal-title":"Sci. Immunol."},{"key":"76940_CR17","doi-asserted-by":"publisher","first-page":"2879","DOI":"10.1016\/j.immuni.2024.10.015","volume":"57","author":"S Sun","year":"2024","unstructured":"Sun, S. et al. Cancer cells restrict immunogenicity of retrotransposon expression via distinct mechanisms. Immunity 57, 2879\u20132894 (2024).","journal-title":"Immunity"},{"key":"76940_CR18","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1158\/2159-8290.CD-24-0094","volume":"15","author":"CA Ishak","year":"2025","unstructured":"Ishak, C. A. et al. Chronic viral mimicry induction following p53 loss promotes immune evasion. Cancer Discov. 15, 793\u2013817 (2025).","journal-title":"Cancer Discov."},{"key":"76940_CR19","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.ccell.2023.03.001","volume":"41","author":"Y Chen","year":"2023","unstructured":"Chen, Y. et al. Epithelial cells activate fibroblasts to promote esophageal cancer development. Cancer Cell 41, 903\u2013918 (2023).","journal-title":"Cancer Cell"},{"key":"76940_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15290","volume":"8","author":"J Chang","year":"2017","unstructured":"Chang, J. et al. Genomic analysis of oesophageal squamous-cell carcinoma identifies alcohol drinking-related mutation signature and genomic alterations. Nat. Commun. 8, 15290 (2017).","journal-title":"Nat. Commun."},{"key":"76940_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-17492-y","volume":"11","author":"J Yao","year":"2020","unstructured":"Yao, J. et al. Single-cell transcriptomic analysis in a mouse model deciphers cell transition states in the multistep development of esophageal cancer. Nat. Commun. 11, 3715 (2020).","journal-title":"Nat. Commun."},{"key":"76940_CR22","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33994-3","volume":"13","author":"H Cui","year":"2022","unstructured":"Cui, H. et al. Characterization of somatic structural variations in 528 Chinese individuals with Esophageal squamous cell carcinoma. Nat. Commun. 13, 6296 (2022).","journal-title":"Nat. Commun."},{"key":"76940_CR23","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1038\/s41588-021-00928-6","volume":"53","author":"S Moody","year":"2021","unstructured":"Moody, S. et al. Mutational signatures in esophageal squamous cell carcinoma from eight countries with varying incidence. Nat. Genet. 53, 1553\u20131563 (2021).","journal-title":"Nat. Genet."},{"key":"76940_CR24","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-37440-w","volume":"14","author":"L Li","year":"2023","unstructured":"Li, L. et al. Integrative proteogenomic characterization of early esophageal cancer. Nat. Commun. 14, 1666 (2023).","journal-title":"Nat. Commun."},{"key":"76940_CR25","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25539-x","volume":"12","author":"X Zhang","year":"2021","unstructured":"Zhang, X. et al. Dissecting esophageal squamous-cell carcinoma ecosystem by single-cell transcriptomic analysis. Nat. Commun. 12, 5291 (2021).","journal-title":"Nat. Commun."},{"key":"76940_CR26","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.ccell.2025.02.009","volume":"43","author":"J Chang","year":"2025","unstructured":"Chang, J. et al. Single-cell multi-stage spatial evolutional map of esophageal carcinogenesis. Cancer cell 43, 380\u2013397 (2025).","journal-title":"Cancer cell"},{"key":"76940_CR27","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.ccell.2023.03.016","volume":"41","author":"Y-X Chen","year":"2023","unstructured":"Chen, Y.-X. et al. An immunogenic and oncogenic feature-based classification for chemotherapy plus PD-1 blockade in advanced esophageal squamous cell carcinoma. Cancer Cell 41, 919\u2013932 (2023).","journal-title":"Cancer Cell"},{"key":"76940_CR28","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1016\/j.ccell.2023.09.011","volume":"41","author":"Z Liu","year":"2023","unstructured":"Liu, Z. et al. Progenitor-like exhausted SPRY1+CD8+ T cells potentiate responsiveness to neoadjuvant PD-1 blockade in esophageal squamous cell carcinoma. Cancer Cell 41, 1852\u20131870 (2023).","journal-title":"Cancer Cell"},{"key":"76940_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-25202-5","volume":"12","author":"W Liu","year":"2021","unstructured":"Liu, W. et al. Large-scale and high-resolution mass spectrometry-based proteomics profiling defines molecular subtypes of esophageal cancer for therapeutic targeting. Nat. Commun. 12, 4961 (2021).","journal-title":"Nat. Commun."},{"key":"76940_CR30","first-page":"1","volume":"6","author":"Y Li","year":"2021","unstructured":"Li, Y. et al. Phosphoproteomics reveals therapeutic targets of esophageal squamous cell carcinoma. Signal Transduct. Target Ther. 6, 1\u20133 (2021).","journal-title":"Signal Transduct. Target Ther."},{"key":"76940_CR31","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.538","volume":"11","author":"X Jin","year":"2021","unstructured":"Jin, X. et al. A multi-omics study delineates new molecular features and therapeutic targets for esophageal squamous cell carcinoma. Clin. Transl. Med. 11, e538 (2021).","journal-title":"Clin. Transl. Med."},{"key":"76940_CR32","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/nmeth.3179","volume":"12","author":"SS Lam","year":"2015","unstructured":"Lam, S. S. et al. Directed evolution of APEX2 for electron microscopy and proximity labeling. Nat. Methods 12, 51\u201354 (2015).","journal-title":"Nat. Methods"},{"key":"76940_CR33","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1158\/1078-0432.CCR-0999-3","volume":"10","author":"XH Tang","year":"2004","unstructured":"Tang, X. H., Knudsen, B., Bemis, D., Tickoo, S. & Gudas, L. J. Oral cavity and esophageal carcinogenesis modeled in carcinogen-treated mice. Clin. Cancer Res. 10, 301\u2013313 (2004).","journal-title":"Clin. Cancer Res."},{"key":"76940_CR34","doi-asserted-by":"publisher","first-page":"2632","DOI":"10.1158\/2159-8290.CD-23-0601","volume":"13","author":"G Efe","year":"2023","unstructured":"Efe, G. et al. p53 gain-of-function mutation induces metastasis via Brd4-dependent Csf-1 expression. Cancer Discov. 13, 2632\u20132651 (2023).","journal-title":"Cancer Discov."},{"key":"76940_CR35","doi-asserted-by":"publisher","first-page":"216154","DOI":"10.1016\/j.canlet.2023.216154","volume":"562","author":"R Feng","year":"2023","unstructured":"Feng, R. et al. Mutant p53 activates hnRNPA2B1-AGAP1-mediated exosome formation to promote esophageal squamous cell carcinoma progression. Cancer Lett. 562, 216154\u2013216166 (2023).","journal-title":"Cancer Lett."},{"key":"76940_CR36","doi-asserted-by":"publisher","first-page":"D61","DOI":"10.1093\/nar\/gkad1069","volume":"52","author":"L Taing","year":"2024","unstructured":"Taing, L. et al. Cistrome Data Browser: integrated search, analysis and visualization of chromatin data. Nucleic Acids Res. 52, D61\u2013D66 (2024).","journal-title":"Nucleic Acids Res."},{"key":"76940_CR37","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/nature15251","volume":"525","author":"J Zhu","year":"2015","unstructured":"Zhu, J. et al. Gain-of-function p53 mutants co-opt chromatin pathways to drive cancer growth. Nature 525, 206\u2013211 (2015).","journal-title":"Nature"},{"key":"76940_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-40352-4","volume":"14","author":"D Ding","year":"2023","unstructured":"Ding, D. et al. Gain-of-function mutant p53 together with ERG proto-oncogene drive prostate cancer by beta-catenin activation and pyrimidine synthesis. Nat. Commun. 14, 4671 (2023).","journal-title":"Nat. Commun."},{"key":"76940_CR39","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1038\/s41579-019-0189-2","volume":"17","author":"WE Johnson","year":"2019","unstructured":"Johnson, W. E. Origins and evolutionary consequences of ancient endogenous retroviruses. Nat. Rev. Microbiol. 17, 355\u2013370 (2019).","journal-title":"Nat. Rev. Microbiol."},{"key":"76940_CR40","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1080\/15548627.2016.1145325","volume":"12","author":"S Aizawa","year":"2016","unstructured":"Aizawa, S. et al. Lysosomal putative RNA transporter SIDT2 mediates direct uptake of RNA by lysosomes. Autophagy 12, 565\u2013578 (2016).","journal-title":"Autophagy"},{"key":"76940_CR41","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1016\/j.cell.2013.07.017","volume":"154","author":"F Halbach","year":"2013","unstructured":"Halbach, F., Reichelt, P., Rode, M. & Conti, E. The yeast ski complex: crystal structure and RNA channeling to the exosome complex. Cell 154, 814\u2013826 (2013).","journal-title":"Cell"},{"key":"76940_CR42","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1158\/2159-8290.CD-23-0486","volume":"14","author":"T Murayama","year":"2024","unstructured":"Murayama, T. et al. Targeting DHX9 triggers tumor-intrinsic interferon response and replication stress in small cell lung cancer. Cancer Discov. 14, 468\u2013491 (2024).","journal-title":"Cancer Discov."},{"key":"76940_CR43","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/s41588-021-00859-2","volume":"53","author":"Z Wu","year":"2021","unstructured":"Wu, Z. et al. Reprogramming of the esophageal squamous carcinoma epigenome by SOX2 promotes ADAR1 dependence. Nat. Genet. 53, 881\u2013894 (2021).","journal-title":"Nat. Genet."},{"key":"76940_CR44","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1158\/0008-5472.CAN-23-2049","volume":"84","author":"Q Zhuang","year":"2024","unstructured":"Zhuang, Q. et al. RNA methyltransferase FTSJ3 regulates the type I interferon pathway to promote hepatocellular carcinoma immune evasion. Cancer Res. 84, 405\u2013418 (2024).","journal-title":"Cancer Res."},{"key":"76940_CR45","doi-asserted-by":"publisher","first-page":"4032","DOI":"10.1016\/j.cell.2021.05.038","volume":"184","author":"SX Lu","year":"2021","unstructured":"Lu, S. X. et al. Pharmacologic modulation of RNA splicing enhances anti-tumor immunity. Cell 184, 4032\u20134047.e31 (2021).","journal-title":"Cell"},{"key":"76940_CR46","doi-asserted-by":"publisher","first-page":"2087","DOI":"10.1016\/j.molcel.2024.05.004","volume":"84","author":"R Zheng","year":"2024","unstructured":"Zheng, R. et al. hnRNPM protects against the dsRNA-mediated interferon response by repressing LINE-associated cryptic splicing. Mol. Cell 84, 2087\u20132103.e8 (2024).","journal-title":"Mol. Cell"},{"key":"76940_CR47","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.ccell.2022.12.004","volume":"41","author":"Z Liu","year":"2023","unstructured":"Liu, Z. et al. Integrated multi-omics profiling yields a clinically relevant molecular classification for esophageal squamous cell carcinoma. Cancer Cell 41, 181\u2013195.e9 (2023).","journal-title":"Cancer Cell"},{"key":"76940_CR48","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-024-01320-9","volume":"16","author":"G Ji","year":"2024","unstructured":"Ji, G. et al. Single-cell profiling of response to neoadjuvant chemo-immunotherapy in surgically resectable esophageal squamous cell carcinoma. Genome Med. 16, 49 (2024).","journal-title":"Genome Med."},{"key":"76940_CR49","doi-asserted-by":"publisher","first-page":"1700","DOI":"10.1136\/gutjnl-2013-305806","volume":"63","author":"J Li","year":"2014","unstructured":"Li, J. et al. LncRNA profile study reveals a three-lncRNA signature associated with the survival of patients with oesophageal squamous cell carcinoma. Gut 63, 1700\u20131710 (2014).","journal-title":"Gut"},{"key":"76940_CR50","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ccell.2019.01.003","volume":"35","author":"TN Gide","year":"2019","unstructured":"Gide, T. N. et al. Distinct immune cell populations define response to anti-PD-1 monotherapy and anti-PD-1\/anti-CTLA-4 combined therapy. Cancer Cell 35, 238\u2013255 (2019).","journal-title":"Cancer Cell"},{"key":"76940_CR51","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.cell.2019.08.012","volume":"179","author":"M Harel","year":"2019","unstructured":"Harel, M. et al. Proteomics of melanoma response to immunotherapy reveals mitochondrial dependence. Cell 179, 236\u2013250 (2019).","journal-title":"Cell"},{"key":"76940_CR52","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.cell.2018.09.006","volume":"175","author":"L Jerby-Arnon","year":"2018","unstructured":"Jerby-Arnon, L. et al. A cancer cell program promotes T Cell exclusion and resistance to checkpoint blockade. Cell 175, 984\u2013997.e24 (2018).","journal-title":"Cell"},{"key":"76940_CR53","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.cell.2023.11.037","volume":"187","author":"J Pozniak","year":"2024","unstructured":"Pozniak, J. et al. A TCF4-dependent gene regulatory network confers resistance to immunotherapy in melanoma. Cell 187, 166\u2013183 (2024).","journal-title":"Cell"},{"key":"76940_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-023-01164-9","volume":"15","author":"J Hu","year":"2023","unstructured":"Hu, J. et al. Tumor microenvironment remodeling after neoadjuvant immunotherapy in non-small cell lung cancer revealed by single-cell RNA sequencing. Genome Med 15, 14 (2023).","journal-title":"Genome Med"},{"key":"76940_CR55","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s12276-020-00493-8","volume":"52","author":"J-W Cho","year":"2020","unstructured":"Cho, J.-W. et al. Genome-wide identification of differentially methylated promoters and enhancers associated with response to anti-PD-1 therapy in non-small cell lung cancer. Exp. Mol. Med. 52, 1550\u20131563 (2020).","journal-title":"Exp. Mol. Med."},{"key":"76940_CR56","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/s41588-024-01998-y","volume":"57","author":"Y Yan","year":"2025","unstructured":"Yan, Y. et al. Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer. Nat. Genet. 57, 126\u2013139 (2025).","journal-title":"Nat. Genet."},{"key":"76940_CR57","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1038\/s43018-022-00450-6","volume":"3","author":"LB Darragh","year":"2022","unstructured":"Darragh, L. B. et al. A phase I\/Ib trial and biological correlate analysis of neoadjuvant SBRT with single-dose durvalumab in HPV-unrelated locally advanced HNSCC. Nat. Cancer 3, 1300\u20131317 (2022).","journal-title":"Nat. Cancer"},{"key":"76940_CR58","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1038\/s41591-018-0101-z","volume":"24","author":"ST Kim","year":"2018","unstructured":"Kim, S. T. et al. Comprehensive molecular characterization of clinical responses to PD-1 inhibition in metastatic gastric cancer. Nat. Med. 24, 1449\u20131458 (2018).","journal-title":"Nat. Med."},{"key":"76940_CR59","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1136\/gutjnl-2024-333617","volume":"74","author":"Y Li","year":"2025","unstructured":"Li, Y. et al. CAF-macrophage crosstalk in tumour microenvironments governs the response to immune checkpoint blockade in gastric cancer peritoneal metastases. Gut 74, 350\u2013363 (2025).","journal-title":"Gut"},{"key":"76940_CR60","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1016\/j.ccell.2023.04.011","volume":"41","author":"J Li","year":"2023","unstructured":"Li, J. et al. Remodeling of the immune and stromal cell compartment by PD-1 blockade in mismatch repair-deficient colorectal cancer. Cancer Cell 41, 1152\u20131169.e7 (2023).","journal-title":"Cancer Cell"},{"key":"76940_CR61","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s41591-021-01323-8","volume":"27","author":"A Bassez","year":"2021","unstructured":"Bassez, A. et al. A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer. Nat. Med. 27, 820\u2013832 (2021).","journal-title":"Nat. Med."},{"key":"76940_CR62","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abn9155","volume":"15","author":"H Song","year":"2023","unstructured":"Song, H. et al. Diverse rescue potencies of p53 mutations to ATO are predetermined by intrinsic mutational properties. Sci. Transl. Med. 15, eabn9155 (2023).","journal-title":"Sci. Transl. Med."},{"key":"76940_CR63","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.ccell.2020.11.013","volume":"39","author":"S Chen","year":"2021","unstructured":"Chen, S. et al. Arsenic trioxide rescues structural p53 mutations through a cryptic allosteric site. Cancer Cell 39, 225\u2013239 (2021).","journal-title":"Cancer Cell"},{"key":"76940_CR64","doi-asserted-by":"publisher","first-page":"24246","DOI":"10.1074\/jbc.M314298200","volume":"279","author":"M Muraki","year":"2004","unstructured":"Muraki, M. et al. Manipulation of alternative splicing by a newly developed inhibitor of Clks. J. Biol. Chem. 279, 24246\u201324254 (2004).","journal-title":"J. Biol. Chem."},{"key":"76940_CR65","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1200\/JCO.2011.40.7783","volume":"30","author":"S Lehmann","year":"2012","unstructured":"Lehmann, S. et al. Targeting p53 in vivo: a first-in-human study with p53-targeting compound APR-246 in refractory hematologic malignancies and prostate cancer. J. Clin. Oncol. 30, 3633\u20133639 (2012).","journal-title":"J. Clin. Oncol."},{"key":"76940_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-33945-y","volume":"13","author":"K Murai","year":"2022","unstructured":"Murai, K. et al. p53 mutation in normal esophagus promotes multiple stages of carcinogenesis but is constrained by clonal competition. Nat. Commun. 13, 6206 (2022).","journal-title":"Nat. Commun."},{"key":"76940_CR67","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41392-023-01710-2","volume":"8","author":"L Chen","year":"2023","unstructured":"Chen, L. et al. Aberrant epithelial cell interaction promotes esophageal squamous-cell carcinoma development and progression. Signal Transduct. Target Ther. 8, 453 (2023).","journal-title":"Signal Transduct. Target Ther."},{"key":"76940_CR68","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1038\/s43018-023-00608-w","volume":"4","author":"P Yao","year":"2023","unstructured":"Yao, P. et al. Protein-level mutant p53 reporters identify druggable rare precancerous clones in noncancerous tissues. Nat. Cancer 4, 1176\u20131192 (2023).","journal-title":"Nat. Cancer"},{"key":"76940_CR69","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.1101\/gad.263202.115","volume":"29","author":"NT Pfister","year":"2015","unstructured":"Pfister, N. T. et al. Mutant p53 cooperates with the SWI\/SNF chromatin remodeling complex to regulate VEGFR2 in breast cancer cells. Genes Dev. 29, 1298\u20131315 (2015).","journal-title":"Genes Dev."},{"key":"76940_CR70","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1111\/febs.14625","volume":"285","author":"P Senapati","year":"2018","unstructured":"Senapati, P. et al. Oncogene c-fos and mutant R175H p53 regulate expression of Nucleophosmin implicating cancer manifestation. FEBS J. 285, 3503\u20133524 (2018).","journal-title":"FEBS J."},{"key":"76940_CR71","doi-asserted-by":"publisher","first-page":"3290","DOI":"10.4161\/cc.21646","volume":"11","author":"T Quante","year":"2012","unstructured":"Quante, T. et al. Mutant p53 is a transcriptional co-factor that binds to G-rich regulatory regions of active genes and generates transcriptional plasticity. Cell Cycle 11, 3290\u20133303 (2012).","journal-title":"Cell Cycle"},{"key":"76940_CR72","doi-asserted-by":"publisher","first-page":"1455","DOI":"10.1515\/BC.2006.182","volume":"387","author":"A Damianov","year":"2006","unstructured":"Damianov, A., Kann, M., Lane, W. S. & Bindereif, A. Human RBM28 protein is a specific nucleolar component of the spliceosomal snRNPs. Biol. Chem. 387, 1455\u20131460 (2006).","journal-title":"Biol. Chem."},{"key":"76940_CR73","doi-asserted-by":"publisher","first-page":"1114","DOI":"10.1016\/j.ajhg.2008.03.014","volume":"82","author":"J Nousbeck","year":"2008","unstructured":"Nousbeck, J. et al. Alopecia, neurological defects, and endocrinopathy syndrome caused by decreased expression of RBM28, a nucleolar protein associated with ribosome biogenesis. Am. J. Hum. Genet. 82, 1114\u20131121 (2008).","journal-title":"Am. J. Hum. Genet."},{"key":"76940_CR74","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/s41586-020-2844-1","volume":"588","author":"P Mehdipour","year":"2020","unstructured":"Mehdipour, P. et al. Epigenetic therapy induces transcription of inverted SINEs and ADAR1 dependency. Nature 588, 169\u2013173 (2020).","journal-title":"Nature"},{"key":"76940_CR75","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/s41586-021-03994-2","volume":"598","author":"S-M Zhang","year":"2021","unstructured":"Zhang, S.-M. et al. KDM5B promotes immune evasion by recruiting SETDB1 to silence retroelements. Nature 598, 682\u2013687 (2021).","journal-title":"Nature"},{"key":"76940_CR76","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1158\/2159-8290.CD-20-1202","volume":"11","author":"E Espinet","year":"2021","unstructured":"Espinet, E. et al. Aggressive PDACs show hypomethylation of repetitive elements and the execution of an intrinsic IFN program linked to a ductal cell of origin. Cancer Discov. 11, 638\u2013659 (2021).","journal-title":"Cancer Discov."},{"key":"76940_CR77","doi-asserted-by":"publisher","first-page":"3090","DOI":"10.1158\/2159-8290.CD-20-1741","volume":"11","author":"X Zhou","year":"2021","unstructured":"Zhou, X. et al. Pharmacologic activation of p53 triggers viral mimicry response thereby abolishing tumor immune evasion and promoting antitumor immunity. Cancer Discov. 11, 3090\u20133105 (2021).","journal-title":"Cancer Discov."},{"key":"76940_CR78","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbc.2021.101524","volume":"298","author":"X Lin","year":"2022","unstructured":"Lin, X. et al. RNA-binding protein RBM28 can translocate from the nucleolus to the nucleoplasm to inhibit the transcriptional activity of p53. J. Biol. Chem. 298, 101524 (2022).","journal-title":"J. Biol. Chem."},{"key":"76940_CR79","doi-asserted-by":"publisher","first-page":"3442","DOI":"10.1038\/s41388-024-03178-y","volume":"43","author":"H Xu","year":"2024","unstructured":"Xu, H. et al. USP36 promotes colorectal cancer progression through inhibition of p53 signaling pathway via stabilizing RBM28. Oncogene 43, 3442\u20133455 (2024).","journal-title":"Oncogene"},{"key":"76940_CR80","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3324\/haematol.2020.259531","volume":"107","author":"R Birsen","year":"2022","unstructured":"Birsen, R. et al. APR-246 induces early cell death by ferroptosis in acute myeloid leukemia. Haematologica 107, 403\u2013416 (2022).","journal-title":"Haematologica"},{"key":"76940_CR81","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1182\/blood-2014-01-548800","volume":"124","author":"B Tessoulin","year":"2014","unstructured":"Tessoulin, B. et al. PRIMA-1Met induces myeloma cell death independent of p53 by impairing the GSH\/ROS balance. Blood 124, 1626\u20131636 (2014).","journal-title":"Blood"},{"key":"76940_CR82","doi-asserted-by":"publisher","first-page":"6516","DOI":"10.7150\/jca.47111","volume":"11","author":"G Zhu","year":"2020","unstructured":"Zhu, G. et al. Arsenic trioxide (ATO) induced degradation of Cyclin D1 sensitized PD-1\/PD-L1 checkpoint inhibitor in oral and esophageal squamous cell carcinoma. J. Cancer 11, 6516\u20136529 (2020).","journal-title":"J. Cancer"},{"key":"76940_CR83","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-018-1417-1","volume":"19","author":"JL Trincado","year":"2018","unstructured":"Trincado, J. L. et al. SUPPA2: fast, accurate, and uncertainty-aware differential splicing analysis across multiple conditions. Genome Biol. 19, 40 (2018).","journal-title":"Genome Biol."},{"key":"76940_CR84","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinforma. 14, 7 (2013).","journal-title":"BMC Bioinforma."},{"key":"76940_CR85","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1038\/s41588-023-01570-0","volume":"55","author":"J Fan","year":"2023","unstructured":"Fan, J. et al. Multiomic analysis of cervical squamous cell carcinoma identifies cellular ecosystems with biological and clinical relevance. Nat. Genet. 55, 2175\u20132188 (2023).","journal-title":"Nat. Genet."},{"key":"76940_CR86","doi-asserted-by":"publisher","first-page":"1550","DOI":"10.1038\/s41591-018-0136-1","volume":"24","author":"P Jiang","year":"2018","unstructured":"Jiang, P. et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nat. Med. 24, 1550\u20131558 (2018).","journal-title":"Nat. Med."},{"key":"76940_CR87","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1093\/bioinformatics\/btv422","volume":"31","author":"Y Jin","year":"2015","unstructured":"Jin, Y., Tam, O. H., Paniagua, E. & Hammell, M. TEtranscripts: a package for including transposable elements in differential expression analysis of RNA-seq datasets. Bioinformatics 31, 3593\u20133599 (2015).","journal-title":"Bioinformatics"},{"key":"76940_CR88","doi-asserted-by":"publisher","first-page":"1347","DOI":"10.1002\/cncr.20916","volume":"103","author":"LR Chirieac","year":"2005","unstructured":"Chirieac, L. R. et al. Posttherapy pathologic stage predicts survival in patients with esophageal carcinoma receiving preoperative chemoradiation. Cancer 103, 1347\u20131355 (2005).","journal-title":"Cancer"},{"key":"76940_CR89","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li, T. et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 48, W509\u2013W514 (2020).","journal-title":"Nucleic Acids Res."},{"key":"76940_CR90","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nature11003","volume":"483","author":"J Barretina","year":"2012","unstructured":"Barretina, J. et al. The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature 483, 603\u2013607 (2012).","journal-title":"Nature"},{"key":"76940_CR91","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.cels.2023.07.007","volume":"14","author":"Y Liao","year":"2023","unstructured":"Liao, Y. et al. A proteogenomics data-driven knowledge base of human cancer. Cell Syst. 14, 777\u2013787 (2023).","journal-title":"Cell Syst."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76940-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76940-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76940-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T00:01:56Z","timestamp":1790208116000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76940-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,25]]},"references-count":91,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["76940"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-76940-3","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,25]]},"assertion":[{"value":"29 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"10165"}}